Coral Labs.

26
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
434.50
7.25 (1.7%)
BSENSE

Mar 19

BSE+NSE Vol: 2

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 37.47% vs 7.09% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 61.58% vs 326.03% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 48,700.00% vs -99.94% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 52.99% vs 144.97% in Mar 2024

Compare Profit and Loss Results of Coral Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
115.00
167.00
-52.00
-31.14%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
115.00
167.00
-52.00
-31.14%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-1.00
4.00
400.00%
Raw Materials Consumed
49.00
85.00
-36.00
-42.35%
Power & Fuel Cost
3.00
15.00
-12.00
-80.00%
Employee Cost
14.00
13.00
1.00
7.69%
Operating Expenses
4.00
13.00
-9.00
-69.23%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
14.00
-12.00
-85.71%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
1.00
4.00
400.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
148.00
-60.00
-40.54%
Operating Profit (PBDIT) excl Other Income
26.00
19.00
7.00
36.84%
Other Income
9.00
4.00
5.00
125.00%
Operating Profit (PBDIT)
35.00
23.00
12.00
52.17%
Interest
0.00
6.00
-6.00
-100.00%
Profit before Depriciation and Tax
35.00
17.00
18.00
105.88%
Depreciation
2.00
8.00
-6.00
-75.00%
Profit Before Taxation & Exceptional Items
33.00
9.00
24.00
266.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
32.00
9.00
23.00
255.56%
Provision for Tax
8.00
2.00
6.00
300.00%
Profit After Tax
24.00
6.00
18.00
300.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
147.00
81.00
66.00
81.48%
Profit Available for appropriations
171.00
87.00
84.00
96.55%
Appropriations
171.00
87.00
84.00
96.55%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
67.61
6.43
61.18
951.48%
Profit And Loss - Net Sales
Net Sales 115.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.47% vs 7.09% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 61.58% vs 326.03% in Mar 2024

Profit And Loss - Interest
Interest 0.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 48,700.00% vs -99.94% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 24.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 52.99% vs 144.97% in Mar 2024